Subscribe to RSS
DOI: 10.1055/s-2007-968019
Total Synthesis and Stereochemical Confirmation of 2,5-Diaryl-3,4-dimethyltetrahydrofuran Lignans: (+)-Fragransin A2, (+)-Galbelgin, (+)-Talaumidin, (-)-Saucernetin and (-)-Verrucosin
Publication History
Publication Date:
07 February 2007 (online)
Abstract
A new ring closure to tetrasubstituted tetrahydrofurans from the intramolecular attack of an OMOM ether onto a benzylic mesylate proceeds through a quinonoid intermediate or by direct SN2 displacement. The synthesis of diastereomeric biologically active natural lignans is described utilizing this general methodology.
Key words
lignans - tetrahydrofurans - quinonoid intermediate - cycloetherification - enantioselective synthesis
- 1
Ward RS. Nat. Prod. Rep. 1995, 12: 183 ; and earlier reviews in this series -
2a
Saleem M.Kim HJ.Ali MS.Lee YS. Nat. Prod. Rep. 2005, 22: 696 - See also:
-
2b
Li G.Ju HK.Chang HW.Jahng Y.Lee S.-H.Son J.-K. Biol. Pharm. Bull. 2003, 26: 1039 -
2c
Lopes NP.Kato MJ.Yoshida M. Phytochemistry 1999, 51: 29 -
2d
Kraft C.Jenett-Siems K.Kohler I.Tofern-Reblin B.Siems K.Bienzle U.Eich E. Phytochemistry 2002, 60: 167 -
2e
Zhai H.Inoue T.Moriyama M.Esumi T.Mitsumoto Y.Fukuyama Y. Biol. Pharm. Bull. 2005, 28: 289 -
2f
Zhai H.Nakatsukasa M.Mitsumoto Y.Fukuyama Y. Planta Med. 2004, 70: 598 -
3a
Hattori M.Hada S.Kawata Y.Tezuka Y.Kikuchi T.Namba T. Chem. Pharm. Bull. 1987, 35: 3315 -
3b
Kasahara H.Miyazawa M.Kameoka H. Phytochemistry 1996, 43: 111 -
4a
Takaoka D.Watanabe K.Hiroi M. Bull. Chem. Soc. Jpn. 1976, 49: 3564 -
4b
Lopes NP.Blumenthal EEA.Cavalheiro AJ.Kato MJ.Yoshida M. Phytochemistry 1996, 43: 1089 -
4c
Parmar VS.Jain SC.Gupta S.Talwar S.Rajwanshi VK.Kumar R.Azim A.Malhotra S.Kumar N.Jain R.Sharma NK.Tyagi OM.Lawrie SJ.Errington W.Howarth OW.Olsen CE.Singh SK.Wengel J. Phytochemistry 1998, 49: 1069 - 5
Vieira LM.Kijjoa A.Silva AHS.Mondranondra I.-O.Herz W. Phytochemistry 1998, 48: 1079 -
6a
Rao KV.Alvarez FM. Tetrahedron Lett. 1983, 24: 4947 -
6b
Rao KV.Oruganty RS. J. Liq. Chromatogr. Relat. Technol. 1997, 20: 3121 -
6c
Hwang BY.Lee J.-H.Nam JB.Hong Y.-S.Lee JJ. Phytochemistry 2003, 64: 765 -
7a
Hossain CF.Kim Y.-P.Baerson SR.Zhang L.Bruick RK.Mohammed KA.Agarwal AK.Nagle DG.Zhou Y.-D. Biochem. Biophys. Res. Commun. 2005, 333: 1026 -
7b
Giang PM.Son PT.Matsunami K.Otsuka H. Chem. Pharm. Bull. 2006, 54: 383 - 8
Konishi T.Konoshima T.Daikonya A.Kitanaka S. Chem. Pharm. Bull. 2005, 53: 121 - 9
Esumi T.Hojyo D.Zhai H.Fukuyama Y. Tetrahedron Lett. 2006, 47: 3979 - 10
Fonseca SF.Barata LES.Ruveda EA. Can. J. Chem. 1979, 57: 441 -
11a
Yu SH.Ferguson MJ.McDonald R.Hall DG. J. Am. Chem. Soc. 2005, 127: 12808 -
11b
Jahn U.Rudakov D. Org. Lett. 2006, 8: 4481 ; and references cited therein -
12a
Biftu T.Gamble NF.Doebber T.Hwang SB.Shen TY.Snyder J.Springer JP.Stevenson R. J. Med. Chem. 1986, 29: 1917 -
12b
Stevenson R.Williams JR. Tetrahedron 1997, 33: 285 - 13
Moinuddin SGA.Hishiyama S.Cho M.-H.Davin LB.Lewis NG. Org. Biomol. Chem. 2003, 1: 2307 - 14
Hanessian S.Reddy GJ.Chahal N. Org. Lett. 2006, 8: 5477 - 15
Imamoto T.Takiyama N.Nakamura K.Hatajima T.Kamiya Y. J. Am. Chem. Soc. 1989, 111: 4392 -
16a
Gemal AL.Luche J.-L. J. Am. Chem. Soc. 1981, 103: 5454 -
16b See also:
Llu C.Burnell DJ. Tetrahedron Lett. 1997, 38: 6573 - 20
Evans DA.Rieger DL.Biodeau MT.Urpi F. J. Am. Chem. Soc. 1991, 113: 1047
References and Notes
Data of (+)-Fragransin A2 (1).
Mp 198-200 °C (Lit.
[3a]
200-202 °C); [α]D +77.7 (c 1.0, CHCl3) [Lit.
[3a]
+79.0 (c 0.84, CHCl3)]. IR (thin film): 3428, 2957, 2926, 1515, 1272, 1034 cm-1. 1H NMR (400 MHz, CDCl3): δ = 6.85-6.98 (m, 6 H), 5.58 (s, 2 H), 4.65 (d, 2 H, J = 9.2 Hz), 3.94 (s, 6 H), 1.76-1.82 (m, 2 H), 1.06 (d, 6 H, J = 6.0 Hz) ppm. 13C NMR (400 MHz, CDCl3): δ = 146.2, 144.7, 134.0, 119.0, 113.6, 108.0, 88.0, 55.6, 50.6, 13.47 ppm. HRMS: m/z calcd for C20H25O5 [M + H]+: 345.1698; found: 345.1696.
Data of (+)-Galbelgin (
2).
Mp 140-142 °C (Lit.
[4c]
141-142 °C); [α]D +83.4 (c 0.47, CHCl3) [Lit.
[4c]
-85.1 (c 0.047, CHCl3) for (-)-galbelgin]. IR (thin film): 2957, 2929, 1515, 1263, 1028 cm-1. 1H NMR (400 MHz, CDCl3): δ = 6.84-7.01 (m, 6 H), 4.68 (d, 2 H, J = 9.2 Hz), 3.93 (s, 6 H), 3.90 (s, 6 H), 1.78-1.87 (m, 2 H), 1.07 (d, 6 H, J = 5.6 Hz) ppm. 13C NMR (400 MHz, CDCl3): δ = 148.6, 148.0, 134.5, 118.2, 110.4, 108.7, 88.0, 55.54, 55.52, 50.6, 13.5 ppm. HRMS: m/z calcd for C22H29O5 [M + H]+: 373.2009; found: 373.2014.
Data of (+)-Talaumidin (
3).
Colorless oil; [α]D +76.0 (c 0.5, CHCl3) [Lit.
[9]
-81.8 (c 0.43, CHCl3) for (-)-talaumidin]. 1H NMR (400 MHz, CDCl3): δ = 6.77-6.97 (m, 6 H), 5.96 (s, 2 H), 5.57 (br s, 1 H), 4.63 (d, 2 H, J = 8.8 Hz), 3.93 (s, 6 H), 1.74-1.82 (m, 2 H), 1.05 (d, 3 H, J = 5.6 Hz), 1.04 (d, 3 H, J = 6.0 Hz) ppm. 13C NMR (400 MHz, CDCl3): δ = 147.4, 146.6, 146.2, 144.7, 136.2, 133.7, 119.3, 119.0, 113.6, 108.1, 107.6, 106.2, 100.6, 88.1, 87.8, 55.6, 50.8, 50.5, 13.45, 13.43 ppm. HRMS: m/z calcd for C20H23O5 [M + H]+: 343.1540; found: 343.1553.
Data of (-)-Verrucosin (
4).
Colorless oil; [α]D -16.14 (c 0.96, CHCl3) [Lit.
[3a]
+14.8 (c 1.38, CHCl3) for (+)-verrucosin]. IR (thin film): 3435, 2937, 2963, 1510, 1266, 1033 cm-1. 1H NMR (400 MHz, CDCl3): δ = 6.81-7.07 (m, 6 H), 5.62 (s, 1 H), 5.56 (s, 1 H), 5.14 (d, 1 H, J = 8.6 Hz), 4.42 (d, 1 H, J = 9.3 Hz), 3.94 (s, 3 H), 3.88 (s, 3 H), 2.19-2.31 (m, 1 H), 1.76-1.86 (m, 1 H), 1.08 (d, 3 H, J = 6.5 Hz), 0.68 (d, 3 H, J = 7.0 Hz) ppm. 13C NMR (100 MHz, CDCl3): δ = 146.1, 145.8, 144.8, 144.2, 132.9, 132.4, 119.5, 118.9, 113.8, 113.5, 109.4, 109.3, 87.0, 82.8, 55.50, 55.46, 47.3, 45.6, 14.6, 14.5 ppm. HRMS: m/z calcd for C20H25O5 [M + H]+: 345.1698; found: 345.1693.
Data of (-)-Saucernetin (
5).
Mp 77-79 °C (Lit.
[6c]
78-80 °C); [α]D -44.2 (c 0.5, CHCl3) [lit.
[6c]
+48.1 (c 0.5, CHCl3)]. IR (thin film): 2957, 2926, 1515, 1272, 1033 cm-1. 1H NMR (400 MHz, CDCl3): δ = 6.85-6.90 (m, 6 H), 5.47 (d, 2 H, J = 6.0 Hz), 3.92 (s, 6 H), 3.90 (s, 6 H), 2.25-2.32 (m, 2 H), 0.71 (d, 6 H, J = 6.4 Hz). 13C NMR (400 MHz, CDCl3): δ = 148.2, 147.5, 133.6, 118.0, 110.3, 109.1, 83.1, 55.5, 43.7, 14.4 ppm. HRMS: m/z calcd for C22H29O5 [M + H]+: 373.2009; found: 373.2014.